Surgery/Specialties

Latest Issue of OR Manager
February 2025
Home Surgery/Specialties

AHA: COVID-19 HIPAA rules for telehealth expire

Editor's Note The American Hospital Association (AHA), on August 9, announced that COVID-19 HIPAA rules for telehealth would expire at 11:59 pm. The Department of Health and Human Services Office for Civil Rights (OCR) implemented a HIPAA policy for telehealth during the COVID-19 public health emergency, which provided enforcement discretion…

Read More

By: Judy Mathias
August 10, 2023
Share

Effect of unmet social health needs on surgical outcomes

Editor's Note This study, led by researchers at the University of Michigan, Ann Arbor, examines opportunities to improve inequitable postoperative outcomes by evaluating unmet social health needs by race, ethnicity, and insurance type. Outcomes included poor health status (self-reported), socioeconomic status (income, education, employment), and unmet social health needs (food,…

Read More

By: Judy Mathias
August 8, 2023
Share

AAOS releases new tools, resources to simplify patient-reported outcome measures

Editor's Note The American Academy of Orthopaedic Surgeons (AAOS), on August 1, released new interactive tools and resources to help collect patient data in advance of mandatory reporting periods. Orthopedic care teams are urged to take note because patient-reported outcome measures (eg, pain, physical mobility, emotional well-being, and experience of…

Read More

By: Judy Mathias
August 8, 2023
Share

Cost-utility of ASC vs inpatient anterior cervical discectomy, fusion

Editor's Note This study from researchers at Carolina Neurosurgery and Spine Associates and SpineFirst, Atrium Health, Charlotte, North Carolina, examines the cost-utility of anterior cervical discectomy and fusion (ACDF) performed in an ASC vs an inpatient hospital setting at 1-year follow-up.  A total of 6,504 patients having 1-to 2-level ACDF…

Read More

By: Judy Mathias
August 3, 2023
Share

Sponsored Message

Association of hospital market competition with high-risk surgical procedure outcomes

Editor's Note This study from the University of Michigan, Ann Arbor, examines the association between hospital market competition and outcomes after high-risk surgical procedures. A total of 2,248,438 Medicare beneficiaries who had 1 of 10 high-risk surgical procedures between 2015 and 2018 were included in the analysis. Compared with low-competition…

Read More

By: Judy Mathias
August 2, 2023
Share

Clinical outcomes, costs of robotic vs open ventral hernia repair

Editor's Note This study led by researchers at Good Samaritan Medical Center, Brockton, Massachusetts, and Tufts University School of Medicine, Boston, examines the clinical outcomes and costs of robotic and open ventral hernia repairs. A total of 675 open and 609 robotic ventral hernia repairs were included in the analysis.…

Read More

By: Judy Mathias
August 1, 2023
Share

Sponsored Message

Costs of frailty after major, elective noncardiac surgery

Editor's Note This Canadian study finds a 1.5-fold increase in costs in the year after major, elective noncardiac surgery for patients with preoperative frailty. A total of 171,576 patients (23,219 with preoperative frailty) were included in the analysis. Unadjusted costs were higher for frail patients. After adjusting for confounders, an…

Read More

By: Judy Mathias
July 31, 2023
Share

FDA: Class I recall of GE HealthCare’s TruSignal SpO2 sensors

Editor's Note The Food and Drug Administration (FDA), on July 28, identified the recall by GE HealthCare of its TruSignal SpO2 [arterial oxygen saturation] sensors as Class I, the most serious. The recall was initiated because of issues that may reduce the amount of energy sent to the heart during…

Read More

By: Judy Mathias
July 31, 2023
Share

FDA: Class I recall of Abiomed Impella Left Sided Blood Pumps

Editor's Note The Food and Drug Administration (FDA), on July 27, identified the recall by Abiomed of all Impella Left Sided Blood Pumps as Class I, the most serious. Abiomed is recalling the pumps because the instructions for use do not adequately address precautions to take when treating transcatheter aortic…

Read More

By: Judy Mathias
July 27, 2023
Share

FDA: Class I recall of Abbott Amplatzer Steerable Delivery Sheath

Editor's Note The Food and Drug Administration (FDA), on July 26, identified the recall by Abbott of its Amplatzer Steerable Delivery Sheath as Class I, the most serious. Abbott is recalling the sheath because of an increased risk for air emboli being introduced into patients who have cardiac catheterization procedures…

Read More

By: Judy Mathias
July 27, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat